WEIGHT LOSS INJECTIONS

Semaglutide is a GLP-1 receptor, it is a FDA approved weight loss program that decreases craving and appetite, increases weight loss, and improves blood glutose control.


Tirzepatide is a dual action GLP- 1 and GIP receptor, it activates GLP-1 like Semaglutide, but also activates GIP (another hormone that impacts appetite and metabolism). The combination of these two enhances the appetite reduction and calorie burn. 

Retatrutide is the next evolution in medical weight management. This triple-action peptide works on GLP-1, GIP, and glucagon receptor, targeting multiple pathways. Retatrutide is designed to go beyond traditional single-hormone treatments — supporting more comprehensive metabolic balance! 



IMG_0849.jpg
IMG_0851.jpg